Lawrence Fong

35PUBLICATIONS
352CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 28, 2026
Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

|Sep 16, 2026
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes.

|Aug 14, 2026
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.

|Apr 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer.

|Jan 20, 2026
Functionally heterogeneous intratumoral CD4+CD8+ double-positive T cells can give rise to single-positive T cells.

Tony Li, Arielle Ilano, Marcel Arias-Badia

|Oct 08, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases.

Bridget P Keenan, Guilin Qiao, Nicholas Kunda

Pageof 6

Frequent Collaborators

6 joint publications

Bridget P Keenan

4 joint publications

Marcel Arias-Badia

4 joint publications

Eliezer M Van Allen

4 joint publications

Li Zhang